MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:76010 chebi:76010 RHWKPHLQXYSBKR-BMIGLBTASA-N | dolutegravir (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide S/GSK1349572 |
kegg.drug:D10066 keggD:D10066 RHWKPHLQXYSBKR-BMIGLBTASA-N | Dolutegravir (USAN) Tivicay (TN) |
| hmdb:HMDB0251580 RHWKPHLQXYSBKR-UHFFFAOYSA-N | Dolutegravir N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0^{3,8}]tetradeca-10,13-diene-13-carboxamide |
CHEBI:76014 chebi:76014 RHWKPHLQXYSBKR-BMIGLBTASA-M | dolutegravir(1-) (4R,12aS)-9-[(2,4-difluorobenzyl)carbamoyl]-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate dolutegravir anion |
keggD:M_D10066 | secondary/obsolete/fantasy identifier |